Aberrant SMARCA4 protein expression was more common in solid-type poorly differentiated adenocarcinomas (49%, 25/51) than in nonsolid-type poorly differentiated adenocarcinomas (7.5%, 3/40) [12], this report did not describe the complete or partial loss of SMARCA4 protein expression. This evidence concerns the gene SMARCA4 and adenocarcinoma.